Found 11 matching trials
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
PHASE1This is a Phase 1, randomized, open-label, 2-way crossover, pharmacokinetic...
Location
Multiple Locations
Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
PHASE2Marqibo (liposomal vincristine) is a form of vincristine preparation. Vincr...
Location
University of California, Los Angeles
Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma
PHASE1This study evaluates addition of Vincristine Sulfate Liposome Injection (Ma...
Location
Rhode Island Hospital and The Miriam Hospital
Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma
PHASE2This study will assess the ability of Doxorubicin, Vincristine and Dexameth...
Location
Ohio State University
Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL
PHASE2Hypotheses: The Investigator hypothesizes that targeting ALL cells with 2 d...
Location
Moffitt Cancer Center
Treatment for Advanced B-Cell Lymphoma
PHASE2To safely reduce the burden of therapy in children, adolescents and young a...
Location
Roswell Park Cancer Institute
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
PHASE2This was a Phase 2, international, multicenter, open-label, single-arm tria...
Location
USC - Norris Cancer Center
Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy
PHASE1This is a pilot study utilizing Marqibo® (vincristine sulfate liposome inje...
Location
Childrens Hospital Los Angeles
Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
PHASE2This is a phase-II study to evaluate the efficacy of a salvage regimen in c...
Location
St. Jude Children's Research Hospital
A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
PHASE3A phase 3 study in the treatment of subjects \>or= 60 years old with newly ...
Location
UC San Diego Moores Cancer Center